|Biogen Idec, Inc.||(NQ: BIIB)|
226.85 USD -1.14 (-0.50%)
Official Closing Price / Updated: 8:10 PM EDT, May 17, 2013 / Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore News
May 15 (Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer drug Rituxan delayed disease progression twice as long as chemotherapy,... Read More
More NewsRead More
Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest EPS Estimates For The Next Quarter
May 15, 2013
Jim Cramer's 5 Investing Sweet Spots
May 14, 2013
category Regeneron Pharmaceuticals Inc , EOG Resources Inc , ENSCO International Incorporated , and 14 more.
from CNBC.com News
Biogen's (BIIB) TECFIDERA Scripts Accelerating WoW
May 13, 2013
from Forbes Real Time
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here